Ignite Creation Date:
2024-05-06 @ 10:07 AM
Last Modification Date:
2024-10-26 @ 12:25 PM
Study NCT ID:
NCT03176381
Status:
COMPLETED
Last Update Posted:
2023-11-14
First Post:
2017-06-01
Brief Title:
Tissue Predictors of Abiraterone Benefit
Sponsor:
Organization:
Tianjin Medical University Second Hospital
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
RNA-seq with IHC of AKR1C3 FKB5 and PCNA were tested in the tissue specimen
Enrollment Count:
110
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 41703 |
Who Masked List: